The recent discovery of gene mutations in a genomic study of myelodysplastic syndromes could enable diagnosis using only a blood test rather than a bone marrow biopsy.
A specific genetic alteration has been identified as a defining feature of epithelioid hemangioendothelioma (EHE), a vascular sarcoma that strikes about 100 people nationwide each year.
Pemetrexed (Alimta) appears to be an effective treatment in persons with non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive.
The finding in experimental models that leukemia stem cells are better at predicting clinical outcome than most acute myeloid leukemia cells has now been demonstrated in human patients.
A new method of assessing ALK gene rearrangement in lung cancer appears to be a relatively easy and inexpensive way to determine whether a person with lung cancer can benefit from the ALK inhibitor crizotinib.
Two small genetic variations can predict which patients with Hodgkin lymphoma are most likely to develop radiation-induced second cancers years after treatment, revealed a recent study.
The first large-scale genomic analysis of gastric cancer confirms that the disease consists of two discrete tumor types that respond differently to chemotherapy.